Focus Advisor Solutions LLC increased its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 88.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,290 shares of the semiconductor company’s stock after purchasing an additional 3,901 shares during the quarter. Focus Advisor Solutions LLC’s holdings in Synopsys were worth $3,606,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of SNPS. Elevation Wealth Partners LLC raised its position in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the last quarter. Osbon Capital Management LLC acquired a new position in Synopsys during the 2nd quarter worth about $25,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys in the 2nd quarter valued at about $28,000. GK Wealth Management LLC bought a new stake in shares of Synopsys in the 3rd quarter valued at about $28,000. Finally, Geneos Wealth Management Inc. grew its position in shares of Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 50 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on SNPS. Morgan Stanley increased their price target on Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a research note on Tuesday, October 20th. Roth Capital raised Synopsys to a “buy” rating in a research note on Friday, September 25th. HSBC cut Synopsys from a “buy” rating to a “reduce” rating in a report on Friday, September 25th. Deutsche Bank reissued a “buy” rating and set a $640.00 target price (up from $590.00) on shares of Synopsys in a research report on Thursday, October 1st. Finally, Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and raised their price target for the stock from $558.00 to $560.00 in a report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and an average target price of $577.71.
Get Our Latest Stock Report on SNPS
Insider Activity at Synopsys
In other news, CFO Sudhindra Kankanwadi sold 9,170 shares of the firm’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the completion of the sale, the chief financial officer directly owned 22,717 shares in the company, valued at $11,358,500. This trade represents a 28.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Janet Lee sold 1,144 shares of the firm’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the completion of the sale, the insider owned 16,534 shares of the company’s stock, valued at approximately $8,308,665.68. This represents a 6.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 117,163 shares of company stock worth $51,366,457 over the last quarter. Company insiders own 0.56% of the company’s stock.
Key Synopsys News
Here’s some of the latest news about SNPS:
- Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
- Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence
- Negative Sentiment: A valuation analysis argues SNPS may be about 17% overvalued despite improving guidance and business performance, raising questions about whether future cash generation justifies the share price. Synopsys may be overvalued
Synopsys Stock Down 8.0%
Synopsys stock opened at $396.55 on Friday. The company has a market capitalization of $76.00 billion, a PE ratio of 44.85, a PEG ratio of 1.40 and a beta of 1.18. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The firm’s fifty day moving average is $448.46 and its 200 day moving average is $440.14. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business had revenue of $2.48 billion during the quarter, compared to analysts’ expectations of $2.44 billion. During the same period last year, the company posted $3.39 earnings per share. The business’s quarterly revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts predict that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.
Synopsys announced that its board has approved a stock buyback plan on Monday, October 5th that permits the company to repurchase $1 billion in outstanding shares. This buyback authorization permits the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its shares are undervalued.
About Synopsys
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
See Also
- Five stocks we like better than Synopsys
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
